Prescription Drug News and Research

RSS

$More patients tested, treated when fracture clinics have someone dedicated to screening$

More patients tested, treated when fracture clinics have someone dedicated to screening

More patients are tested and treated for osteoporosis when fracture clinics have someone dedicated to screening for the bone disease, a new study has found.

12 Jul 2011

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced an exclusive licensing agreement for Watson to commercialize Antares' topical oxybutynin gel product in the U.S. and Canada.

11 Jul 2011

Generics as a way to lower health care costs

As the nation seeks to expand health care coverage to more citizens without adding burdensome costs, researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark reported that preventative health care may be significantly less costly than previously thought, due to expanded use of cost-effective generic medications for the treatment and prevention of chronic disease.

8 Jul 2011

Viewpoints: Debt ceiling & entitlements; Pharmaceutical dilemmas; Bishops 'misunderstand' death with dignity

Democrats have already proposed a 3-1 formula that would allow for $3 in spending cuts for every $1 in new revenue. So we have met our Republican colleagues more than half-way in this painful process. We are even willing to discuss significant savings in Medicare and Medicaid — as long as essential benefits for seniors and the most vulnerable are preserved (Rep. William Lacy Clay, 7/7).

8 Jul 2011

State roundup: Health officials in Calif. draw high pay

Abortion-rights supporters worried Tuesday that regulations Kansas is trying to enact would give the state health department unfettered access to patient medical records and suggested it could endanger the privacy of women who have terminated pregnancies.

7 Jul 2011

Treating migraines with behavioral approaches can make financial sense

Treating chronic migraines with behavioral approaches - such as relaxation training, hypnosis and biofeedback - can make financial sense compared to prescription-drug treatment, especially after a year or more, a new study found.

6 Jul 2011

Viewpoints: 'Imaginary' mandates, premium hikes, Medicare leadership

Liberals are taking a victory lap since a federal appeals court upheld President Obama's health care plan last week, but not so fast. This is an idiosyncratic and flawed opinion, and we trust the Supreme Court, however it rules, will hold itself to a higher standard of jurisprudential reasoning.

6 Jul 2011

Obama administration turns bright spotlight on prescription painkiller abuse

The Obama administration turned a bright spotlight on prescription painkiller abuse in April when the Office of National Drug Control Policy released a national action plan and a statement from Vice President Joe Biden.

2 Jul 2011

Multinational drug companies' scam

In an Al Jazeera opinion piece, the first in a two-part series, Khadija Sharife, a journalist and visiting scholar at the Center for Civil Society, examines how multinational drug companies control markets.

1 Jul 2011

HHS: Half million seniors experiencing lower drug costs

As a result of health law changes to provide seniors with "doughnut hole" relief, Medicare recipients saved a combined $260 million on medicines as of the end of last month.

30 Jun 2011

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that it has entered into a definitive distribution and supply agreement with Vertical Pharmaceuticals, Inc., a U.S.-based specialty pharmaceutical company, under which Cipher has granted Vertical the exclusive right to market, sell and distribute CIP-TRAMADOL ER in the United States.

29 Jun 2011

Drug labels sometimes lack key safety warnings: Consumer Reports Health

It's comparable to driving a car without a seatbelt—a new investigation from Consumer Reports Health finds that drug labels sometimes lack key safety warnings and some pharmacies fail to include the medication guides required by the federal government.

28 Jun 2011

Cardium to purchase Transdel's business assets

Cardium Therapeutics today announced that it had entered into an agreement with Transdel Pharmaceuticals to acquire substantially all of Transdel's business assets including a Phase 3 product candidate Ketotransdel (TDLP-110), which is a topically-administered analgesic for the treatment of musculoskeletal pain.

27 Jun 2011

EMA acceptance of brentuximab vedotin MAA triggers $5M milestone payment to Seattle Genetics

Seattle Genetics, Inc., today announced that it will receive a $5 million milestone payment under its brentuximab vedotin (ADCETRIS) collaboration with Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.

27 Jun 2011

FDA accepts for filing Columbia's PROCHIEVE progesterone gel NDA

Columbia Laboratories, Inc. and Watson Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Columbia's New Drug Application (NDA) for PROCHIEVE (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.

27 Jun 2011

FDA issues Complete Response Letter for Pfizer's REMOXY NDA

DURECT Corporation today reported that Pfizer Inc. has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for REMOXY, a controlled-release form of oxycodone designed to discourage common methods of tampering.

27 Jun 2011

Supreme Court sides with drug makers in two decisions

One would shield pharmaceutical companies from most lawsuits filed by people injured by taking generic drugs. The other strikes down a Vermont law that banned some commercial uses — "data mining" — of prescription data.

24 Jun 2011

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Endo Pharmaceuticals announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of OPANA ER has been accepted.

24 Jun 2011

Rite Aid reports net loss of $63.1 million for first quarter ended May 28, 2011

Rite Aid Corporation today reported financial results for the first quarter ended May 28, 2011.

23 Jun 2011

State roundup: N.J. Gov. Christie's big health care changes

The state Senate voted 24-15 to pass legislation that will force public employees to pay more for their health insurance and pension. The vote, after hours of speeches from lawmakers on both sides, leaves only the Assembly to sign off on the bill that was a focal piece of Gov. Chris Christie's agenda.

22 Jun 2011